The first Amylyx Pharmaceuticals trade was made in Q1 2022.
Since then Andreas Halvorsen bought shares two more times and sold shares on four occasions. The investor completely sold their stake between Q4 2022 and Q1 2024.
Avg closing price
Price range
Sold -2.96 Million shares
Q1 2024
Avg closing price
$13.08
Price range
$2.71
-
$19.57
Sold 36.1% shares (-1.67 Million shares)
Q1 2023
Avg closing price
$34.74
Price range
$27.71
-
$40.93
Sold 19.7% shares (-1.14 Million shares)
Q4 2022
Avg closing price
$35.49
Price range
$29.75
-
$39.26
Increased shares by 211.8% (+3.92 Million shares)
Q3 2022
Avg closing price
$24.95
Price range
$17.15
-
$30.92
Sold 74.2% shares (-5.32 Million shares)
Sep 08, 2022
Avg closing price
$27.03
Price range
$27.03
-
$27.03
Increased shares by 211.8% (+4.87 Million shares)
Q1 2022